Australia's largest stock trading and investment forum Australia's #1 stock forum

AVR

Click for more information

0.00%

$12.00 anteris technologies ltd

News: AHZ Admedus Says Cardiocel 3D And Vascucel Receives European Regulatory Approval, page-255

First 255 Last

Share
Profile

Follow
centro11

2,765 Posts.

286

19/03/19

13:16

Post #: 37809910
Share

Originally posted by pauljbo470: ↑

WP has next to no financial consequence for his performance, that is reserved for the shareholders. His last 2 interviews have been a farce.
I like his quote about the 'shareprice going up and down'. Not much up happening, but a lot of down in the last FY

He can rattle on as much as he likes about the old investors underestimating the capital requirements for development going forward. These expectations came about due to his words about, cost control and revenue guidance. But now its because the shareholders didnt get it.

I get it , you only need to look at some of the expenditure items in the yearly

Employee benefits $23,513,819
Research and development costs $3,372,965

There is only one reason this company is burning through cash, and it isnt because of retail investors having a poor understanding of the capital requirements for development.

WP earns $1.2 and throws a token $50K at a raising.

Where is the consequence of his failure to control spend and miss guidance by so much. He just shrugs it off.

How did he get it so wrong
Remember the investor presentation 18 months ago that started with this slide, to help investors understand how the company was going.

View attachment 1481249
Hows that train looking now?

Expand

AHZ Price at posting: 3.9¢ Sentiment: Sell Disclosure: Not Held
9 Upvote

6 Great analysis

Reply

Top Stories

AHK

Ark Mines provides strategic update following mining lease submission

TTT

Titomic jumps +6% as it incorporates Microsoft Hololens tech

STK

Rogozna grows with gold equivalent grading 1.1g/t across 545.7m for Strickland

RCE

Recce progresses testing of gel to treat bacterial skin infections

LU7

The Breakdown: Lithium Universe talks refinery design and lithium processing in strong preliminary feasibility study for Bécancour

There are more pages in this discussion • 313 more messages in this thread...

First 255 Last

Add AVR (ASX) to my watchlist

(20min delay)
Last $12.00		Change 0.000(0.00%)		Mkt cap ! $253.6M

Open	High	Low	Value	Volume
$11.88	$12.00	$11.50	$261.8K	22.14K

Buyers (Bids)

No.	Vol.	Price($)
1	156	$11.80

Sellers (Offers)

Price($)	Vol.	No.
$12.00	6045	3

View Market Depth

No.	Vol.	Price($)
1	156	11.800
1	870	11.600
1	2	11.260
1	8	11.220
1	1000	11.200

Price($)	Vol.	No.
12.000	6045	3
12.400	198	1
12.500	429	1
12.850	1000	1
13.000	4000	2

Last trade - 16.10pm 09/10/2024 (20 minute delay)

AVR (ASX) Chart

SPONSORED BY